Clot Chronicles: The Perils of Discontinuing Anticoagulation in Afib—Findings from the GARFIELD-AF Registry
Hello, I’m Dr. Sam Goldhaber, President of NATF, and I’m here on Clot Chronicles to discuss a recent study of…
August 15, 2021
Provider
March 15, 2021
Clot Chronicles: Challenging Situations in Patients with Cancer-Associated Thrombosis
Hello, my name is Tzu-Fei Wang. I’m a hematologist at the Ottawa Hospital and the University of Ottawa in Ontario,…
February 19, 2021
COVID, Thrombosis, and the Research: Steering into the Storm with Full Sails
This program addressed the unique cardiovascular (CV) risks and challenges that patients face when recovering from COVID-19, with a particular…
January 14, 2021
Managing Cardiovascular Risk in Women: Updated Guidance
NATF is pleased to partner with ScientiaCME to offer online continuing medical education programs. Please log in on the ScientiaCME website to…
December 15, 2020
Food for Thought: Vitamins, Diet, and Anticoagulation
Tara Lech, PharmD is an Anticoagulation and Cardiovascular Clinical Pharmacy Specialist and currently serves as the Thrombosis Program Manager at…
November 24, 2020
Direct Oral Anticoagulants (DOACs) vs. Warfarin: Key Differences
Updated November 2020 For over half a century, vitamin K antagonists (VKAs) such as warfarin were the only available oral…
November 24, 2020
A Guide to INR Levels
Updated November 2020 After being diagnosed with a blood clot (thrombosis), your healthcare provider may prescribe warfarin for treatment. Warfarin…
November 23, 2020
Inflammation, Diet, Health, and Clots: What You Need to Know
Updated November 2020 Inflammation is a hot topic in the medical community and has been shown to increase the risk of thrombosis and…